GSK3B, CPTAC-804 - CPTAC Assay Portal (original) (raw)

Please include the following statement when referencing the CPTAC Assay Portal

We would like to acknowledge the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) Assay Portal (assays.cancer.gov) for developing assays and establishing criteria for the assays described in this publication.

Protein Sequence hover to view complete sequence

CPTAC-5749: View additional LLEYTPTAR data
non-CPTAC-5556: View additional LLEYTPTAR data
non-CPTAC-5556: View additional LLEYTPTAR data

non-CPTAC-5403: View additional QTLPVIYVK data

10 20 30 40 50
MSGRPRTTSF AESCKPVQQP SAFGSMKVSR DKDGSKVTTV VATPGQGPDR
60 70 80 90 100
PQEVSYTDTK VIGNGSFGVV YQAKLCDSGE LVAIKKVLQD KRFKNRELQI
110 120 130 140 150
MRKLDHCNIV RLRYFFYSSG EKKDEVYLNL VLDYVPETVY RVARHYSRAK
160 170 180 190 200
QTLPVIYVKL YMYQLFRSLA YIHSFGICHR DIKPQNLLLD PDTAVLKLCD
210 220 230 240 250
FGSAKQLVRG EPNVSYICSR YYRAPELIFG ATDYTSSIDV WSAGCVLAEL
260 270 280 290 300
LLGQPIFPGD SGVDQLVEII KVLGTPTREQ IREMNPNYTE FKFPQIKAHP
310 320 330 340 350
WTKVFRPRTP PEAIALCSRL LEYTPTARLT PLEACAHSFF DELRDPNVKL
360 370 380 390 400
PNGRDTPALF NFTTQELSSN PPLATILIPP HARIQAAAST PTNATAASDA
410 420
NTGDRGQTNN AASASASNST

Data source: UniProt


Position of Targeted Peptide Analytes Relative to SNPs, Isoforms, and PTMs

Uniprot Database Entry PhosphoSitePlus ®

Click a point on a node

to view detailed assay information below

All other points link out to UniProt


Phosphorylation Acetylation Ubiquitylation Other

loading

Loader


Assay Details for CPTAC-5749 Collapse assay details

Data source: Panorama

Official Gene Symbol

GSK3B

Peptide Sequence

LLEYTPTAR

Modification Type

unmodified

Protein - Site of Modification

N/A

Peptide - Site of Modification

3

Peptide Start

320

Peptide End

328

CPTAC ID

CPTAC-5749

Peptide Molecular Mass

1,062.5710

Species

Homo sapiens (Human)

Assay Type

Enrichment PRM

Enrichment Method

N/A

Matrix

Cell Lysate

Submitting Laboratory

Fred Hutchinson Cancer Research Center, H. Lee Moffitt Cancer Center & Research Institute, Broad Institute

Submitting Lab PI

Amanda Paulovich, John Koomen, Steven A. Carr


Publication

View Details (opens in a new window)

Targeted mass spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP Kinase, and AKT signaling. Whiteaker JR, Sharma K, Hoffman MA, Kuhn E, Zhao L, Cocco AR, Schoenherr RM, Kennedy JJ, Voytovich U, Lin C, Fang B, Bowers K, Whiteley G, Colantonio S, Bocik W, Roberts R, Hiltke T, Boja E, Rodriguez H, McCormick F, Holderfield M, Carr SA, Koomen JM, Paulovich AG. Cell Reports Methods doi: 10.1016/j.crmeth.2021.100015.


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument

SCIEX 5500 / Thermo Quantiva

Internal Standard

Stable Isotope Labeled Standard

Peptide Standard Purity

>95%

Peptide Standard Label Type

13C and 15N at C-terminus R

LC

Dionex Ultimate 3000

Column Packing

C18 PepMap 100

Column Dimensions

75 micron ID x 25 cm length

Flow Rate

300 nL/min


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader


Repeatability

Data source: Panorama

| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CVequation | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | y4 (1+) | 15.1 | 8.7 | 4.5 | 23.5 | 23 | 10.9 | 27.9 | 24.6 | 11.8 | 15 | 15 | 15 | | y6 (1+) | 25.2 | 8.9 | 4.4 | 31.5 | 20.1 | 11.6 | 40.3 | 22 | 12.4 | 15 | 15 | 15 | | y7 (1+) | 28.5 | 7.4 | 3.9 | 18.6 | 23.1 | 11 | 34 | 24.3 | 11.7 | 15 | 15 | 15 | | sum | 18.8 | 7.3 | 3.9 | 21.1 | 22.1 | 11.1 | 28.3 | 23.3 | 11.8 | 15 | 15 | 15 |



Additional Resources and Comments


Assay Details for CPTAC-5750 Collapse assay details

Data source: Panorama

Official Gene Symbol

GSK3B

Peptide Modified Sequence

TPPEAIALC[+57.021464]SR

Modification Type

Carbamidomethyl (C)

Protein - Site of Modification

N/A

Peptide - Site of Modification

3

Peptide Start

309

Peptide End

319

CPTAC ID

CPTAC-5750

Peptide Molecular Mass

1,213.6125

Species

Homo sapiens (Human)

Assay Type

Enrichment PRM

Enrichment Method

N/A

Matrix

Cell Lysate

Submitting Laboratory

Fred Hutchinson Cancer Research Center, H. Lee Moffitt Cancer Center & Research Institute, Broad Institute

Submitting Lab PI

Amanda Paulovich, John Koomen, Steven A. Carr


Publication

View Details (opens in a new window)

Targeted mass spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP Kinase, and AKT signaling. Whiteaker JR, Sharma K, Hoffman MA, Kuhn E, Zhao L, Cocco AR, Schoenherr RM, Kennedy JJ, Voytovich U, Lin C, Fang B, Bowers K, Whiteley G, Colantonio S, Bocik W, Roberts R, Hiltke T, Boja E, Rodriguez H, McCormick F, Holderfield M, Carr SA, Koomen JM, Paulovich AG. Cell Reports Methods doi: 10.1016/j.crmeth.2021.100015.


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument

SCIEX 5500 / Thermo Quantiva

Internal Standard

Stable Isotope Labeled Standard

Peptide Standard Purity

>95%

Peptide Standard Label Type

13C and 15N at C-terminus R

LC

Dionex Ultimate 3000

Column Packing

C18 PepMap 100

Column Dimensions

75 micron ID x 25 cm length

Flow Rate

300 nL/min


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader


Repeatability

Data source: Panorama

| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CVequation | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | y9 (1+) | 21.3 | 12.3 | 5.6 | 23.1 | 27 | 15.2 | 31.4 | 29.7 | 16.2 | 15 | 15 | 15 | | y5 (1+) | 43.1 | 12.8 | 6.4 | 44.4 | 26.8 | 12.7 | 61.9 | 29.7 | 14.2 | 15 | 15 | 15 | | sum | 24 | 10.9 | 4.5 | 23.9 | 26.4 | 13.9 | 33.9 | 28.6 | 14.6 | 15 | 15 | 15 |



Additional Resources and Comments


Assay Details for CPTAC-5790 Collapse assay details

Data source: Panorama

Official Gene Symbol

GSK3B

Peptide Modified Sequence

TTSFAESC[+57.021464]KPVQQPSAFGSMK

Modification Type

Carbamidomethyl (C)

Protein - Site of Modification

N/A

Peptide - Site of Modification

3

Peptide Start

7

Peptide End

27

CPTAC ID

CPTAC-5790

Peptide Molecular Mass

2,287.0613

Species

Homo sapiens (Human)

Assay Type

Enrichment PRM

Enrichment Method

N/A

Matrix

Cell Lysate

Submitting Laboratory

Fred Hutchinson Cancer Research Center, H. Lee Moffitt Cancer Center & Research Institute, Broad Institute

Submitting Lab PI

Amanda Paulovich, John Koomen, Steven A. Carr


Publication

View Details (opens in a new window)

Targeted mass spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP Kinase, and AKT signaling. Whiteaker JR, Sharma K, Hoffman MA, Kuhn E, Zhao L, Cocco AR, Schoenherr RM, Kennedy JJ, Voytovich U, Lin C, Fang B, Bowers K, Whiteley G, Colantonio S, Bocik W, Roberts R, Hiltke T, Boja E, Rodriguez H, McCormick F, Holderfield M, Carr SA, Koomen JM, Paulovich AG. Cell Reports Methods doi: 10.1016/j.crmeth.2021.100015.


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument

SCIEX 5500 / Thermo Quantiva

Internal Standard

Stable Isotope Labeled Standard

Peptide Standard Purity

>95%

Peptide Standard Label Type

13C and 15N K

LC

Dionex Ultimate 3000

Column Packing

C18 PepMap 100

Column Dimensions

75 micron ID x 25 cm length

Flow Rate

300 nL/min


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader


Repeatability

Data source: Panorama

| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CVequation | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | y15 (2+) | 12.1 | 4.2 | 9 | 16.7 | 16 | 12.4 | 20.6 | 16.5 | 15.3 | 16 | 15 | 17 | | y8 (1+) | 14.1 | 4.1 | 9.2 | 19.5 | 15 | 12.4 | 24.1 | 15.6 | 15.4 | 16 | 15 | 17 | | sum | 13 | 3.6 | 9.1 | 18.1 | 15.3 | 12.4 | 22.3 | 15.7 | 15.4 | 16 | 15 | 17 |



Additional Resources and Comments


Assay Details for CPTAC-5791 Collapse assay details

Data source: Panorama

Official Gene Symbol

GSK3B

Peptide Modified Sequence

TTS[+79.966331]FAESC[+57.021464]KPVQQPSAFGSMK

Modification Type

Carbamidomethyl (C)

Protein - Site of Modification

N/A

Peptide - Site of Modification

3

Peptide Start

7

Peptide End

27

CPTAC ID

CPTAC-5791

Peptide Molecular Mass

2,367.0276

Species

Homo sapiens (Human)

Assay Type

Enrichment PRM

Enrichment Method

N/A

Matrix

Cell Lysate

Submitting Laboratory

Fred Hutchinson Cancer Research Center, H. Lee Moffitt Cancer Center & Research Institute, Broad Institute

Submitting Lab PI

Amanda Paulovich, John Koomen, Steven A. Carr


Publication

View Details (opens in a new window)

Targeted mass spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP Kinase, and AKT signaling. Whiteaker JR, Sharma K, Hoffman MA, Kuhn E, Zhao L, Cocco AR, Schoenherr RM, Kennedy JJ, Voytovich U, Lin C, Fang B, Bowers K, Whiteley G, Colantonio S, Bocik W, Roberts R, Hiltke T, Boja E, Rodriguez H, McCormick F, Holderfield M, Carr SA, Koomen JM, Paulovich AG. Cell Reports Methods doi: 10.1016/j.crmeth.2021.100015.


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument

SCIEX 5500 / Thermo Quantiva

Internal Standard

Stable Isotope Labeled Standard

Peptide Standard Purity

>95%

Peptide Standard Label Type

13C and 15N K

LC

Dionex Ultimate 3000

Column Packing

C18 PepMap 100

Column Dimensions

75 micron ID x 25 cm length

Flow Rate

300 nL/min


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader


Repeatability

Data source: Panorama

| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CVequation | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | y8 (1+) | 8.5 | 9.7 | 13.4 | 17.8 | 19.2 | 19.7 | 19.7 | 21.5 | 23.8 | 16 | 15 | 16 | | y15 (2+) | 15.2 | 10.6 | 10.6 | 23.9 | 17.9 | 14.9 | 28.3 | 20.8 | 18.3 | 16 | 15 | 16 | | sum | 9.1 | 9.9 | 11.7 | 19 | 18.6 | 16.8 | 21.1 | 21.1 | 20.5 | 16 | 15 | 16 |



Additional Resources and Comments


Assay Details for CPTAC-5751 Collapse assay details

Data source: Panorama

Official Gene Symbol

GSK3B

Peptide Sequence

VIGNGSFGVVYQAK

Modification Type

unmodified

Protein - Site of Modification

N/A

Peptide - Site of Modification

3

Peptide Start

61

Peptide End

74

CPTAC ID

CPTAC-5751

Peptide Molecular Mass

1,437.7616

Species

Homo sapiens (Human)

Assay Type

Enrichment PRM

Enrichment Method

N/A

Matrix

Cell Lysate

Submitting Laboratory

Fred Hutchinson Cancer Research Center, H. Lee Moffitt Cancer Center & Research Institute, Broad Institute

Submitting Lab PI

Amanda Paulovich, John Koomen, Steven A. Carr


Publication

View Details (opens in a new window)

Targeted mass spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP Kinase, and AKT signaling. Whiteaker JR, Sharma K, Hoffman MA, Kuhn E, Zhao L, Cocco AR, Schoenherr RM, Kennedy JJ, Voytovich U, Lin C, Fang B, Bowers K, Whiteley G, Colantonio S, Bocik W, Roberts R, Hiltke T, Boja E, Rodriguez H, McCormick F, Holderfield M, Carr SA, Koomen JM, Paulovich AG. Cell Reports Methods doi: 10.1016/j.crmeth.2021.100015.


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument

SCIEX 5500 / Thermo Quantiva

Internal Standard

Stable Isotope Labeled Standard

Peptide Standard Purity

>95%

Peptide Standard Label Type

13C and 15N at C-terminus K

LC

Dionex Ultimate 3000

Column Packing

C18 PepMap 100

Column Dimensions

75 micron ID x 25 cm length

Flow Rate

300 nL/min


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader


Repeatability

Data source: Panorama

| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CVequation | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | y4 (1+) | 29.9 | 10.1 | 7.7 | 23.8 | 27.8 | 13.9 | 38.2 | 29.6 | 15.9 | 15 | 15 | 15 | | y5 (1+) | 26.5 | 15.6 | 5.7 | 24.4 | 32.5 | 13.7 | 36 | 36.1 | 14.8 | 15 | 15 | 15 | | y7 (1+) | 24.6 | 11.1 | 6.5 | 22.3 | 27.4 | 14.3 | 33.2 | 29.6 | 15.7 | 15 | 15 | 15 | | sum | 24.2 | 11.5 | 6.5 | 20.5 | 29.1 | 13.8 | 31.7 | 31.3 | 15.3 | 15 | 15 | 15 |



Additional Resources and Comments


Assay Details for non-CPTAC-5556 Collapse assay details

Data source: Panorama

Official Gene Symbol

GSK3B

Peptide Sequence

LLEYTPTAR

Modification Type

unmodified

Protein - Site of Modification

N/A

Peptide - Site of Modification

6

Peptide Start

320

Peptide End

328

CPTAC ID

non-CPTAC-5556

Peptide Molecular Mass

1,062.5710

Species

Homo sapiens (Human)

Assay Type

Enrichment PRM

Enrichment Method

N/A

Matrix

Cell Line

Submitting Laboratory

Moffitt Cancer Center

Submitting Lab PI

John Koomen


Publication

View Details (opens in a new window)

Targeted mass spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP Kinase, and AKT signaling. Whiteaker JR, Sharma K, Hoffman MA, Kuhn E, Zhao L, Cocco AR, Schoenherr RM, Kennedy JJ, Voytovich U, Lin C, Fang B, Bowers K, Whiteley G, Colantonio S, Bocik W, Roberts R, Hiltke T, Boja E, Rodriguez H, McCormick F, Holderfield M, Carr SA, Koomen JM, Paulovich AG. Cell Reports Methods doi: 10.1016/j.crmeth.2021.100015.


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument

RSLCnano and Quantiva

Internal Standard

SIS Peptide

Peptide Standard Purity

>95%

Peptide Standard Label Type

13C and 15N at C-terminus R

LC

RSLCnano

Column Packing

C18 PepMap100

Column Dimensions

75 micron ID x 25 cm length

Flow Rate

300 nL/min


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader


Repeatability

Data source: Panorama

| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CVequation | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | y4 (1+) | 16.1 | 5.9 | 4 | 23.8 | 23.3 | 10.5 | 28.7 | 24 | 11.2 | 14 | 14 | 14 | | y5 (1+) | 23.8 | 7.5 | 4.1 | 26.7 | 23.9 | 11.6 | 35.8 | 25 | 12.3 | 14 | 14 | 14 | | y6 (1+) | 21.2 | 6.3 | 3.3 | 29.3 | 20.5 | 11 | 36.2 | 21.4 | 11.5 | 14 | 14 | 14 | | y7 (1+) | 21.4 | 4.1 | 3.2 | 20.7 | 23.6 | 11 | 29.8 | 24 | 11.5 | 14 | 14 | 14 | | sum | 18.2 | 4.1 | 3.2 | 22.8 | 22.7 | 10.9 | 29.2 | 23.1 | 11.4 | 14 | 14 | 14 |



Additional Resources and Comments


Assay Details for non-CPTAC-5403 Collapse assay details

Data source: Panorama

Official Gene Symbol

GSK3B

Peptide Sequence

QTLPVIYVK

Modification Type

unmodified

Protein - Site of Modification

N/A

Peptide - Site of Modification

N/A

Peptide Start

151

Peptide End

159

CPTAC ID

non-CPTAC-5403

Peptide Molecular Mass

1,059.6328

Species

Homo sapiens (Human)

Assay Type

Direct PRM

Matrix

Cell Lysate

Submitting Laboratory

Moffitt Cancer Center

Submitting Lab PI

John Koomen


Publication

View Details (opens in a new window)

Targeted mass spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP Kinase, and AKT signaling. Whiteaker JR, Sharma K, Hoffman MA, Kuhn E, Zhao L, Cocco AR, Schoenherr RM, Kennedy JJ, Voytovich U, Lin C, Fang B, Bowers K, Whiteley G, Colantonio S, Bocik W, Roberts R, Hiltke T, Boja E, Rodriguez H, McCormick F, Holderfield M, Carr SA, Koomen JM, Paulovich AG. Cell Reports Methods doi: 10.1016/j.crmeth.2021.100015.


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument

RSLCnano and Quantiva

Internal Standard

Stable Isotope Labeled Standard

Peptide Standard Purity

>95%

Peptide Standard Label Type

13C and 15N at C-terminus K

LC

RSLCnano

Column Packing

C18 PepMap 100

Column Dimensions

75 micron ID x 25 cm length

Flow Rate

300 nl/min


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader


Repeatability

Data source: Panorama

| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CVequation | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | y6 (1+) | 4.2 | 2.8 | 2.6 | 6.1 | 3 | 3.7 | 7.4 | 4.1 | 4.5 | 15 | 15 | 15 | | y7 (1+) | 9.4 | 6.3 | 3.8 | 6.3 | 7.2 | 4.1 | 11.3 | 9.6 | 5.6 | 15 | 15 | 15 | | y3 (1+) | 9 | 4.1 | 3.4 | 11.5 | 4.5 | 3.2 | 14.6 | 6.1 | 4.7 | 15 | 15 | 15 | | y5 (1+) | 18.1 | 6.8 | 5.3 | 20.9 | 6.4 | 4.2 | 27.6 | 9.3 | 6.8 | 15 | 15 | 15 | | sum | 4.1 | 2 | 2.1 | 6.2 | 2.7 | 2.9 | 7.4 | 3.4 | 3.6 | 15 | 15 | 15 |



Additional Resources and Comments


Assay Details for non-CPTAC-5404 Collapse assay details

Data source: Panorama

Official Gene Symbol

GSK3B

Peptide Modified Sequence

TPPEAIALC[+57.021464]SR

Modification Type

Carbamidomethyl (C)

Protein - Site of Modification

318

Peptide - Site of Modification

9

Peptide Start

309

Peptide End

319

CPTAC ID

non-CPTAC-5404

Peptide Molecular Mass

1,213.6125

Species

Homo sapiens (Human)

Assay Type

Direct PRM

Matrix

Cell Lysate

Submitting Laboratory

Moffitt Cancer Center

Submitting Lab PI

John Koomen


Publication

View Details (opens in a new window)

Targeted mass spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP Kinase, and AKT signaling. Whiteaker JR, Sharma K, Hoffman MA, Kuhn E, Zhao L, Cocco AR, Schoenherr RM, Kennedy JJ, Voytovich U, Lin C, Fang B, Bowers K, Whiteley G, Colantonio S, Bocik W, Roberts R, Hiltke T, Boja E, Rodriguez H, McCormick F, Holderfield M, Carr SA, Koomen JM, Paulovich AG. Cell Reports Methods doi: 10.1016/j.crmeth.2021.100015.


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument

RSLCnano and Quantiva

Internal Standard

Stable Isotope Labeled Standard

Peptide Standard Purity

>95%

Peptide Standard Label Type

13C and 15N at C-terminus R

LC

RSLCnano

Column Packing

C18 PepMap 100

Column Dimensions

75 micron ID x 25 cm length

Flow Rate

300 nl/min


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader


Repeatability

Data source: Panorama

| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CVequation | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | y9 (1+) | 2.4 | 1.7 | 1.8 | 3.3 | 2.1 | 1.9 | 4.1 | 2.7 | 2.6 | 15 | 15 | 15 | | y5 (1+) | 6 | 2.5 | 1.4 | 5.5 | 3.5 | 3.4 | 8.1 | 4.3 | 3.7 | 15 | 15 | 15 | | y6 (1+) | 9.1 | 2.4 | 2.3 | 9.9 | 2.9 | 4.6 | 13.4 | 3.8 | 5.1 | 15 | 15 | 15 | | y7 (1+) | 5.7 | 2.2 | 2.7 | 6 | 2.5 | 4.4 | 8.3 | 3.3 | 5.2 | 15 | 15 | 15 | | y8 (1+) | 8.2 | 3 | 3.5 | 7.5 | 4 | 3.3 | 11.1 | 5 | 4.8 | 15 | 15 | 15 | | sum | 2.2 | 1.2 | 1.4 | 2.5 | 1.6 | 2.7 | 3.3 | 2 | 3 | 15 | 15 | 15 |



Additional Resources and Comments


Assay Details for non-CPTAC-5401 Collapse assay details

Data source: Panorama

Official Gene Symbol

GSK3B

Peptide Modified Sequence

TTSFAESC[+57.021464]KPVQQPSAFGSMK

Modification Type

Carbamidomethyl (C)

Protein - Site of Modification

15

Peptide - Site of Modification

8

Peptide Start

7

Peptide End

27

CPTAC ID

non-CPTAC-5401

Peptide Molecular Mass

2,287.0613

Species

Homo sapiens (Human)

Assay Type

Direct PRM

Matrix

Cell Lysate

Submitting Laboratory

Moffitt Cancer Center

Submitting Lab PI

John Koomen


Publication

View Details (opens in a new window)

Targeted mass spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP Kinase, and AKT signaling. Whiteaker JR, Sharma K, Hoffman MA, Kuhn E, Zhao L, Cocco AR, Schoenherr RM, Kennedy JJ, Voytovich U, Lin C, Fang B, Bowers K, Whiteley G, Colantonio S, Bocik W, Roberts R, Hiltke T, Boja E, Rodriguez H, McCormick F, Holderfield M, Carr SA, Koomen JM, Paulovich AG. Cell Reports Methods doi: 10.1016/j.crmeth.2021.100015.


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument

RSLCnano and Quantiva

Internal Standard

Stable Isotope Labeled Standard

Peptide Standard Purity

>95%

Peptide Standard Label Type

13C and 15N K

LC

RSLCnano

Column Packing

C18 PepMap 100

Column Dimensions

75 micron ID x 25 cm length

Flow Rate

300 nl/min


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader


Repeatability

Data source: Panorama

| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CVequation | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | y16 (2+) | 7.5 | 4.9 | 3.3 | 9.6 | 5.7 | 4.9 | 12.2 | 7.5 | 5.9 | 15 | 15 | 15 | | y17 (2+) | 11 | 5.1 | 4.2 | 11.4 | 5.9 | 4.5 | 15.8 | 7.8 | 6.2 | 15 | 15 | 15 | | y19 (2+) | 10.4 | 4.1 | 3 | 12.8 | 7.3 | 3.7 | 16.5 | 8.4 | 4.8 | 15 | 15 | 15 | | y8 (1+) | 7 | 2.6 | 2.9 | 8.1 | 6.3 | 3.4 | 10.7 | 6.8 | 4.5 | 15 | 15 | 15 | | y12 (1+) | 20 | 10.5 | 5.6 | 16.6 | 6.7 | 6.6 | 26 | 12.5 | 8.7 | 15 | 15 | 15 | | sum | 3.3 | 2.1 | 1.8 | 5.1 | 3.8 | 2.9 | 6.1 | 4.3 | 3.4 | 15 | 15 | 15 |



Additional Resources and Comments


Assay Details for non-CPTAC-5705 Collapse assay details

Data source: Panorama

Official Gene Symbol

GSK3B

Peptide Modified Sequence

TTS[+79.966331]FAESC[+57.021464]KPVQQPSAFGSMK

Modification Type

Carbamidomethyl (C)

Protein - Site of Modification

N/A

Peptide - Site of Modification

3

Peptide Start

7

Peptide End

27

CPTAC ID

non-CPTAC-5705

Peptide Molecular Mass

2,367.0276

Species

Homo sapiens (Human)

Assay Type

Enrichment PRM

Enrichment Method

N/A

Matrix

Cell Lysate

Submitting Laboratory

Moffitt Cancer Center

Submitting Lab PI

John Koomen


Publication

View Details (opens in a new window)

Targeted mass spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP Kinase, and AKT signaling. Whiteaker JR, Sharma K, Hoffman MA, Kuhn E, Zhao L, Cocco AR, Schoenherr RM, Kennedy JJ, Voytovich U, Lin C, Fang B, Bowers K, Whiteley G, Colantonio S, Bocik W, Roberts R, Hiltke T, Boja E, Rodriguez H, McCormick F, Holderfield M, Carr SA, Koomen JM, Paulovich AG. Cell Reports Methods doi: 10.1016/j.crmeth.2021.100015.


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument

Thermo Quantiva

Internal Standard

peptide

Peptide Standard Purity

>95%

Peptide Standard Label Type

13C and 15N K

LC

Dionex Ultimate 3000 RSLCnano

Column Packing

Pepmap 100

Column Dimensions

75um x 25cm

Flow Rate

300 nL/min


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader


Repeatability

Data source: Panorama

| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CVequation | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | y8 (2+) | 12.7 | 4.9 | 5.7 | 13 | 6.8 | 7.5 | 18.2 | 8.4 | 9.4 | 15 | 15 | 15 | | y8 (1+) | 3.4 | 3.7 | 2.3 | 4.5 | 4 | 3.8 | 5.6 | 5.4 | 4.4 | 15 | 15 | 15 | | y17 (2+) | 8.6 | 10.5 | 5.4 | 10.5 | 11.6 | 6.1 | 13.6 | 15.6 | 8.1 | 15 | 15 | 15 | | y16 (2+) | 5.9 | 5.2 | 4.4 | 6.8 | 8.1 | 6.4 | 9 | 9.6 | 7.8 | 15 | 15 | 15 | | y15 (2+) | 10.6 | 7.9 | 4.9 | 10.7 | 8.3 | 5.3 | 15.1 | 11.5 | 7.2 | 15 | 15 | 15 | | sum | 3.6 | 2.8 | 1.8 | 4 | 3.2 | 2.4 | 5.4 | 4.3 | 3 | 15 | 15 | 15 |



Additional Resources and Comments


Assay Details for non-CPTAC-5554 Collapse assay details

Data source: Panorama

Official Gene Symbol

GSK3B

Peptide Sequence

VIGNGSFGVVYQAK

Modification Type

unmodified

Protein - Site of Modification

N/A

Peptide - Site of Modification

6

Peptide Start

61

Peptide End

74

CPTAC ID

non-CPTAC-5554

Peptide Molecular Mass

1,437.7616

Species

Homo sapiens (Human)

Assay Type

Enrichment PRM

Enrichment Method

N/A

Matrix

Cell Line

Submitting Laboratory

Moffitt Cancer Center

Submitting Lab PI

John Koomen


Publication

View Details (opens in a new window)

Targeted mass spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP Kinase, and AKT signaling. Whiteaker JR, Sharma K, Hoffman MA, Kuhn E, Zhao L, Cocco AR, Schoenherr RM, Kennedy JJ, Voytovich U, Lin C, Fang B, Bowers K, Whiteley G, Colantonio S, Bocik W, Roberts R, Hiltke T, Boja E, Rodriguez H, McCormick F, Holderfield M, Carr SA, Koomen JM, Paulovich AG. Cell Reports Methods doi: 10.1016/j.crmeth.2021.100015.


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument

RSLCnano and Quantiva

Internal Standard

SIS Peptide

Peptide Standard Purity

>95%

Peptide Standard Label Type

13C and 15N at C-terminus K

LC

RSLCnano

Column Packing

C18 PepMap100

Column Dimensions

75 micron ID x 25 cm length

Flow Rate

300 nL/min


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader


Repeatability

Data source: Panorama

| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CVequation | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | y4 (1+) | 28.4 | 9.3 | 7.3 | 22.9 | 28.5 | 13.2 | 36.5 | 30 | 15.1 | 14 | 14 | 14 | | y5 (1+) | 29 | 12.7 | 5.9 | 25.8 | 33.4 | 13.5 | 38.8 | 35.7 | 14.7 | 14 | 14 | 14 | | y7 (1+) | 26.5 | 9.6 | 5.1 | 23.5 | 28.8 | 12.6 | 35.4 | 30.4 | 13.6 | 14 | 14 | 14 | | y8 (1+) | 29.1 | 10.8 | 3.8 | 30.6 | 33.8 | 13.9 | 42.2 | 35.5 | 14.4 | 14 | 14 | 14 | | y12 (1+) | 23.7 | 8.2 | 6.9 | 30.9 | 27.3 | 14.2 | 38.9 | 28.5 | 15.8 | 14 | 14 | 14 | | sum | 25.6 | 9.3 | 5.8 | 24.5 | 29.8 | 13.3 | 35.4 | 31.2 | 14.5 | 14 | 14 | 14 |



Additional Resources and Comments


Assay Details for CPTAC-3039 Collapse assay details

Data source: Panorama

Official Gene Symbol

GSK3B

Peptide Sequence

DIKPQNLLLDPDTAVLK

Modification Type

unmodified

Protein - Site of Modification

N/A

Peptide - Site of Modification

N/A

Peptide Start

181

Peptide End

197

CPTAC ID

CPTAC-3039

Peptide Molecular Mass

1,892.0619

Species

Homo Sapiens

Assay Type

Direct PRM

Matrix

Tumor Digest

Submitting Laboratory

Washington University in St. Louis

Submitting Lab PI

Reid Townsend


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument

ThermoFisher, Q-Exactive

Internal Standard

25 fmol on column

Peptide Standard Purity

>95%

Peptide Standard Label Type

13C and 15N at C-terminus K

LC

Easy-nLC 1000 Thermo Scientific

Column Packing

C18

Column Dimensions

75 µm x 50 cm

Flow Rate

300 nL/min


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader


Repeatability

Data source: Panorama

| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CVequation | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | b6 (1+) | 5.3 | 8 | 7.1 | 7.5 | 13.7 | 12.2 | 9.2 | 15.9 | 14.1 | 15 | 15 | 15 | | y7 (1+) | 5.2 | 7.5 | 7.2 | 7.7 | 12.8 | 12.3 | 9.3 | 14.8 | 14.3 | 15 | 15 | 15 | | b7 (1+) | 5.4 | 8.2 | 7.4 | 7.5 | 14.1 | 12.2 | 9.2 | 16.3 | 14.3 | 15 | 15 | 15 | | sum | 4.9 | 7.8 | 7.1 | 7.2 | 13.3 | 12.1 | 8.7 | 15.4 | 14 | 15 | 15 | 15 |



Additional Resources and Comments


Assay Details for CPTAC-3038 Collapse assay details

Data source: Panorama

Official Gene Symbol

GSK3B

Peptide Modified Sequence

LTPLEAC[+57.0]AHSFFDELR

Modification Type

Carbamidomethyl (C)

Protein - Site of Modification

336

Peptide - Site of Modification

7

Peptide Start

329

Peptide End

344

CPTAC ID

CPTAC-3038

Peptide Molecular Mass

1,904.9091

Species

Homo Sapiens

Assay Type

Direct PRM

Matrix

Tumor Digest

Submitting Laboratory

Washington University in St. Louis

Submitting Lab PI

Reid Townsend


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument

ThermoFisher, Q-Exactive

Internal Standard

25 fmol on column

Peptide Standard Purity

>95%

Peptide Standard Label Type

13C and 15N at C-terminus R

LC

Easy-nLC 1000 Thermo Scientific

Column Packing

C18

Column Dimensions

75 µm x 50 cm

Flow Rate

300 nL/min


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader


Repeatability

Data source: Panorama

| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CVequation | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | y7 (1+) | 4 | 6.3 | 8.9 | 6.2 | 16.6 | 16.1 | 7.4 | 17.8 | 18.4 | 15 | 15 | 15 | | y8 (1+) | 3.9 | 6.6 | 8.6 | 6 | 17.2 | 16.3 | 7.2 | 18.4 | 18.4 | 15 | 15 | 15 | | y3 (1+) | 4.4 | 4.8 | 10.8 | 5.9 | 12.7 | 15.6 | 7.4 | 13.6 | 19 | 15 | 15 | 15 | | sum | 3.3 | 5.9 | 9.2 | 5.4 | 15.9 | 15.9 | 6.3 | 17 | 18.4 | 15 | 15 | 15 |



Additional Resources and Comments


Assay Details for CPTAC-804 Collapse assay details

Data source: Panorama

Official Gene Symbol

GSK3B

Peptide Modified Sequence

TTS[+80.0]FAESC[+57.0]KPVQQPSAFGSMK

Modification Type

Phospho (ST), Carbamidomethyl Cysteine

Protein - Site of Modification

9, 14

Peptide - Site of Modification

3, 8

Peptide Start

7

Peptide End

27

CPTAC ID

CPTAC-804

Peptide Molecular Mass

2,367.0276

Species

Homo sapiens (Human)

Assay Type

Direct PRM

Matrix

Pooled patient derived xenograft breast tumor digest

Submitting Laboratory

Washington University in St. Louis

Submitting Lab PI

Reid Townsend


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument

TripleTOF 5600+ (SCIEX)

Internal Standard

Peptide

Peptide Standard Purity

Crude

Peptide Standard Label Type

13C and 15N at C-terminus K

LC

2DPlus nano-LC (Eksigent)

Column Packing

ChromXP C18-CL, 3 µm, 120 Å

Column Dimensions

200 µm x 15 cm

Flow Rate

800 nL/min


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader


Repeatability

Data source: Panorama

| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CVequation | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | y3 (1+) | 25.6 | 12.5 | 8.5 | 33.1 | 17.8 | 10.8 | 41.8 | 21.8 | 13.7 | 15 | 15 | 15 | | y4 (1+) | 28.8 | 15.5 | 9 | 19.8 | 15.7 | 13.3 | 34.9 | 22.1 | 16.1 | 15 | 15 | 15 | | y5 (1+) | 21.1 | 11 | 10.5 | 18.8 | 9.3 | 10.6 | 28.3 | 14.4 | 14.9 | 15 | 15 | 15 | | y6 (1+) | 23.2 | 12.1 | 6 | 21.6 | 15.9 | 8.9 | 31.7 | 20 | 10.7 | 15 | 15 | 15 | | y7 (1+) | 24.9 | 7.7 | 18.6 | 26.9 | 8.4 | 15.7 | 36.7 | 11.4 | 24.3 | 15 | 15 | 15 | | y8 (1+) | 8.9 | 6.6 | 2.9 | 9 | 7 | 5.6 | 12.7 | 9.6 | 6.3 | 15 | 15 | 15 | | y12 (1+) | 9.9 | 9.1 | 9.2 | 13.6 | 8.1 | 10.9 | 16.8 | 12.2 | 14.3 | 15 | 15 | 15 | | sum | 6.5 | 4.2 | 1.8 | 7 | 4.9 | 3.6 | 9.6 | 6.5 | 4 | 15 | 15 | 15 |



Additional Resources and Comments